Interventional Procedure Guidance is developed for most of the novel interventional procedures entering the English market. The program focuses solely on the clinical evidence. Recommendations may vary from ‘for research only’ to ‘for use with standard arrangements for clinical governance, consent, and audit.' Recommendations are not binding, although they are followed by providers and commissioners.
In the first half of June NICE published one new Interventional Procedure Guidance Intranasal phototherapy for allergic rhinitis, which covers evidence-based recommendations on ntranasal phototherapy using light to reduce inflammation inside the nose. Current evidence on the efficacy and safety of intranasal phototherapy for allergic rhinitis is limited in quantity and quality. Therefore, this procedure should only be used in the context of research.
MedTech Innovation Briefing is the NICE's advice program for innovative technologies. It provides an overview of clinical effectiveness, safety and cost. It does not offer a formal guidance, and it, therefore, does not provide any recommendations.
One new Medtech Innovation Briefing for VIDAvision for lung volume analysis in emphysema has been published in the first half of June. VIDAvision is used for lung volume analysis in people with advanced emphysema who are being considered for lung reduction procedures.
See full details here.
Subscribe to our newsletter delivered every second week not to miss important reimbursement information.